A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
for Acute Leukemia
23 locations incl. Duarte
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 2+
Code: NCT04811560·Phase 1, Phase 2·Recruiting·Listed Mar 2021
Clinical research site in Providence, Rhode Island · 400 RESERVOIR AVE STE 2G, PROVIDENCE, RI 02907-3594 · (401) 632-4470
Part of Maine Health
As of July 2026, 1 paid clinical trial is recruiting at Maine Health in Providence, Rhode Island. Active studies at this site focus on Acute Leukemia alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Paid clinical trials in Providence, RI · Rhode Island clinical trials